0001878961-22-000001.txt : 20220707 0001878961-22-000001.hdr.sgml : 20220707 20220707163629 ACCESSION NUMBER: 0001878961-22-000001 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220627 FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anderson Glen R. CENTRAL INDEX KEY: 0001878961 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 221072034 MAIL ADDRESS: STREET 1: 3274 ROSS ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 347-480-9760 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2022-06-27 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001878961 Anderson Glen R. 101 SOUTH 200 EAST, SUITE 700 SALT LAKE CITY UT 84111 0 0 1 0 Common Stock 113918 D Common Stock 973130 I By Anderson Family Trust u/a dtd 01/07/2018 (1) On June 27, 2022, Reporting Person acquired 19,467 shares of common stock at $2.06 per share, resulting in total beneficial ownership as of June 27, 2022, of 844,970 shares of common stock or 10.23% of the outstanding common stock. Since June 27, 2022, Reporting Person has made the following purchases in the market: 61,360 shares at $2.22 per share on 6/28/2022; 57,620 shares at $2.39 per share on 6/29/2022; 79,400 shares at $2.99 per share on 7/1/2022; and 43,698 shares at $3.09 per share on 7/5/2022, for a total beneficial ownership of 1,087,048 shares of common stock as of July 5, 2022 or 13.16% of the outstanding common stock. Glen R. Anderson 2022-07-07